- Home
- TRVI vs AMN Comparison
TRVI vs AMN Comparison
Compare TRVI & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AMN
- Stock Information
- Founded
- TRVI 2011
- AMN 1985
- Country
- TRVI United States
- AMN United States
- Employees
- TRVI N/A
- AMN N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AMN Assisted Living Services
- Sector
- TRVI Health Care
- AMN Health Care
- Exchange
- TRVI Nasdaq
- AMN Nasdaq
- Market Cap
- TRVI 725.7M
- AMN 775.3M
- IPO Year
- TRVI 2019
- AMN 2001
- Fundamental
- Price
- TRVI $7.01
- AMN $20.86
- Analyst Decision
- TRVI Strong Buy
- AMN Hold
- Analyst Count
- TRVI 10
- AMN 8
- Target Price
- TRVI $19.35
- AMN $28.25
- AVG Volume (30 Days)
- TRVI 2.0M
- AMN 1.1M
- Earning Date
- TRVI 11-05-2025
- AMN 11-06-2025
- Dividend Yield
- TRVI N/A
- AMN N/A
- EPS Growth
- TRVI N/A
- AMN N/A
- EPS
- TRVI N/A
- AMN N/A
- Revenue
- TRVI N/A
- AMN $2,769,926,000.00
- Revenue This Year
- TRVI N/A
- AMN N/A
- Revenue Next Year
- TRVI N/A
- AMN N/A
- P/E Ratio
- TRVI N/A
- AMN N/A
- Revenue Growth
- TRVI N/A
- AMN N/A
- 52 Week Low
- TRVI $2.36
- AMN $14.87
- 52 Week High
- TRVI $8.78
- AMN $53.78
- Technical
- Relative Strength Index (RSI)
- TRVI 44.05
- AMN 58.60
- Support Level
- TRVI $7.09
- AMN $19.54
- Resistance Level
- TRVI $8.78
- AMN $20.91
- Average True Range (ATR)
- TRVI 0.43
- AMN 0.92
- MACD
- TRVI -0.07
- AMN 0.13
- Stochastic Oscillator
- TRVI 4.32
- AMN 83.20
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.